Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer.

Familial cancer - 1 Mar 2012

Ståhlbom Anne Kinhult, Johansson Hemming, Liljegren Annelie, von Wachenfeldt Anna, Arver Brita

Abstract excerpt

The ability of the Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA) model to predict BRCA1 and BRCA2 mutations and breast cancer incidence in women with a family history of breast cancer was evaluated. Observed mutations in 263 screened families were compared to retrospective predictions. Similarly, observed breast cancers in 640 women were compared to retrospective...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Carcinoma, Intraductal, Noninfiltrating

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Incidence

Share to Models, Theoretical

Share to Mutation Rate

Share to Risk Assessment

Share to ROC Curve

Source

Open in PubMed Open full text

Identifiers

PMID: 22124624
DOI: 10.1007/s10689-011-9495-1
PMCID: PMC3297752

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer.PMID 22124624Read ↗

BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface.Semantic proximity Read ↗

Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium.Semantic proximity Read ↗

The BOADICEA model of genetic susceptibility to breast and ovarian cancer.Semantic proximity Read ↗

Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study.Semantic proximity Read ↗

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.Semantic proximity Read ↗

Incorporating tumour pathology information into breast cancer risk prediction algorithms.Semantic proximity Read ↗

Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genesSemantic proximity Read ↗

Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes.Semantic proximity Read ↗

Validation of the BOADICEA Model in a Prospective Cohort of<i>BRCA1/2</i>Pathogenic Variant CarriersSemantic proximity Read ↗

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.Semantic proximity Read ↗

Validation of the BOADICEA model in a prospective cohort of BRCA1/2 pathogenic variant carriers.Semantic proximity Read ↗

Performance of BOADICEA and BRCAPRO genetic models and of empirical criteria based on cancer family history for predicting BRCA mutation carrier probabilities: a retrospective study in a sample of Italian cancer genetics clinics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.